In 2023, antacid medicine sales in Italy were valued at approximately 28.8 million euros. The forecast indicates a steady increase in sales, reaching 31.5 million euros by 2028. This reflects a year-on-year growth rate of about 1.7% to 1.9% for the years from 2024 to 2028. The compound annual growth rate (CAGR) over the forecast period is anticipated to be around 1.8%.
Future trends to watch for include:
- The impact of lifestyle changes and dietary habits on antacid demand.
- The introduction of new, more effective formulations or delivery methods.
- Potential regulatory changes impacting the pharmaceutical industry in Italy.
